跳至主要内容
临床试验/NCT05741593
NCT05741593招募中不适用

Qualitative Analysis of Interviews Between Pharmacist and Elderly Patients Treated with Antithrombotics for an Ischemic Stroke.

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
Analysis of the verbatim from the transcription of the recorded interviews.

研究概览

简要总结

Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. There are brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.

详细描述

Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. The probability of stroke recurrence is high: about 25% the first year , and 30 to 40% in the 5 years following the stroke. Recurrent strokes are responsible for significant disability, institutionalization, major neurocognitive disorders, and death.

In order to reduce the risk of stroke recurrence, multiple secondary prevention strategies have demonstrated their effectiveness, such as the prescription of drugs (in particular statins and antithrombotics), the establishment of a balanced diet, the practice of an activity physical, or even tobacco addiction.

However, the effectiveness of these strategies is optimal if and only if patients adhere to them.

In addition, previous studies have focused on the brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.

In elderly patients, other obstacles could have been identified by specific studies, such as cognitive, sensory, functional disorders or even isolation.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
65 Years 至 100 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 65 and over
  • Patients hospitalized for an ischemic stroke or a recurrence of ischemic stroke, already being treated with an antithrombotic treatment (antiplatelet agent or anticoagulant ) prior to the stroke
  • Patients living at home and with a plan to return home.
  • Patients who did not object to the study and who gave their consent for the recording of the interview

排除标准

  • Patients with cognitive disorders or stroke sequelae that do not allow a semi-directive interview to be carried out (at medical discretion).
  • Non-French speaking patients

结局指标

主要结局

Analysis of the verbatim from the transcription of the recorded interviews.

时间窗: one year

Describing the content of discussions, relating to antithrombotic treatment for secondary prevention, between elderly patients previously treated with antithrombotics and admitted to hospital for an ischemic stroke and a pharmacist

次要结局

  • Analysis of verbatim statements from the transcription of recorded interviews on patients' representations and beliefs regarding antithrombotics(15 to 60 minutes per patient)
  • Analysis of verbatim statements from the transcription of recorded interviews on patients' medication adherence to antithrombotics(15 to 60 minutes per patient)
  • Analysis of verbatim statements from the transcription of recorded interviews on the impact of the occurrence of stroke or recurrence of stroke on medication adherence(15 to 60 minutes per patient)
  • Analysis of verbatim statements from the transcription of recorded interviews on the obstacles and levers to medication adherence(15 to 60 minutes per patient)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验